Business Context and Reporting Period
This Form 8-K Current Report was filed by Uppercut Brands, Inc. (not Silo Pharma, Inc.) on April 29, 2020, reporting events occurring on April 28, 2020. The filing details a private placement of equity securities and related agreements.
Key Financial Metrics and Transaction Details
- Transaction Type: Private Placement of Common Stock.
- Shares Issued: 29,993,750 shares.
- Price Per Share: $0.08.
- Gross Proceeds: $2,399,500.
- Use of Proceeds: Working capital and execution of existing business plans.
- Placement Agents: Bradley Woods & Co. Ltd. (Exclusive) and Katalyst Securities (Sub-Agent).
Material Changes and Agreements
The Company entered into several material definitive agreements on the Closing Date:
- Securities Purchase Agreement: Established the terms of the private placement with institutional and accredited investors.
- Registration Rights Agreement: The Company agreed to file a registration statement within 30 days to allow resale of the shares. Failure to do so triggers liquidated damages of 1% per month (capped at 6%) of the subscription amount.
- Lock-Up Agreement: All officers and directors agreed not to sell their shares or equivalents for 12 months following the Closing Date.
- Participation Rights: Investors contributing over $100,000 have the right to participate in up to 50% of any subsequent financing within six months on the same terms.
Guidance, Outlook, and Risks
The filing does not provide specific financial guidance, revenue forecasts, or management commentary regarding future performance beyond the stated use of proceeds for working capital. The primary risk disclosed relates to the Company's obligation to file a registration statement; failure to meet the 30-day deadline results in monetary penalties to investors.
Investor Verification Checklist
- Verify the actual net proceeds after deducting placement agent fees and offering expenses, as only gross proceeds ($2,399,500) are stated.
- Confirm the dilution impact of issuing nearly 30 million shares at $0.08 per share on existing shareholders.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific covenants and representations.
- Monitor the Company's compliance with the 30-day registration filing deadline to avoid liquidated damages.
- Check subsequent filings to confirm if the 12-month lock-up for officers and directors remains in effect.